Education
About Us
Working with TipRanks
Follow Us
Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
ARDT Stock Chart & Stats
$9.01
$0.02(0.12%)
At close: 4:00 PM EST
$9.01
$0.02(0.12%)
Day’s Range― - ―
52-Week Range$8.07 - $15.59
Previous CloseN/A
Volume15.92K
Average Volume (3M)407.60K
Market Cap
$1.28B
Enterprise Value$2.96B
Total Cash (Recent Filing)$609.44M
Total Debt (Recent Filing)$2.28B
Price to Earnings (P/E)6.2
Beta0.53
Next Earnings
Mar 04, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding143,187,680
10 Day Avg. Volume333,763
30 Day Avg. Volume407,603
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)2.00
Price to Sales (P/S)0.38
P/FCF Ratio17.74
Enterprise Value/Market Cap2.31
Enterprise Value/Revenue0.47
Enterprise Value/Gross Profit0.66
Enterprise Value/Ebitda5.36
Forecast
1Y Price Target
$13.73Price Target Upside52.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost Savings ProgramAnalysts expect the IMPACT program to deliver a labor cost run-rate benefit near $40 million by early 2026, which could meaningfully reduce margin pressure and support profitability.
Joint Venture StrategyA unique joint-venture strategy focused on outpatient expansion could broaden market reach and create new revenue streams, supporting longer-term growth diversification.
Volume GrowthReported volume growth of about 2.9% year-over-year, reaching the high end of full-year guidance, indicates resilient demand across admissions and surgeries that can sustain revenue stability.
Bears Say
Analyst Downgrades And Price Target CutsAnalyst downgrades and lower price targets reflect diminished investor confidence and could amplify selling pressure on the stock.
Earnings Guidance RevisionsMaterial downward revisions to adjusted EBITDA guidance reduce visibility into future cash generation and signal weaker operational performance than previously expected.
Payor Denials And Professional FeesRising payor denials and elevated professional fees, including radiology subsidies, have compressed adjusted EBITDA and may continue to exert pressure on margins.
Ardent Health Partners, Inc. News
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $8.07 and its highest was $15.59 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.28B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Mar 04, 2026 which is in 20 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on Nov 12, 2025. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of $0.419 by -$0.589.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.32.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 143,187,680 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of -$0.17 in its last earnings report, missing expectations of $0.419. Following the earnings report the stock price went down -33.808%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.73 (52.39% Upside)
$13.73 (52.39% Upside)
Hedge Fund Trend
Increased
By 493.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 11.0%
Last 30 Days ▼ 11.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.97%
12-Months-Change
Fundamentals
Return on Equity
18.28%
Trailing 12-Months
Asset Growth
9.08%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
ARDT Company Deck
ARDT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected strong revenue and EBITDA growth and robust demand in key markets. However, persistent cost pressures, particularly from professional fees and payer denials, led to a revision in EBITDA guidance. The IMPACT program is a positive step towards cost optimization, but industry headwinds remain a challenge.View all ARDT earnings summariesARDT Stock 12 Month Forecast
Average Price Target
$13.73
▲(52.39% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Aveanna Healthcare Holdings
―
Ownership Overview
Currently, No data available
---